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Abstract
Background: Pagets disease of the nipple presents as an eczematous lesion, occurs in 1 – 4% of
all female breast carcinoma cases and is invariably associated with underlying malignancy either
overt or occult. The majority of these cases are invasive disease although 40–45% are associated
with DCIS.
Case presentation: A 39 year old lady presented to our unit with a palpable lump in the right
breast. Radiological and histological investigation proved this to be an extensive area of Ductal
Carcinoma in Situ (DCIS) for which she underwent a simple mastectomy and immediate latissimus
dorsi flap reconstruction. Histology revealed high grade DCIS with 2 small foci of invasive
carcinoma. At 1 year the patient represented with a nodule adjacent to the reconstruction scar
which was proved on biopsy to be consistent with Paget's disease. This was proved on formal
excision.
Conclusion: In the absence of underlying breast or apocrine tissue this case details a case of
Paget's disease of uncertain origin.
Background
Pagets disease of the nipple accounts for between 1–4% of
all cases of female breast carcinoma and presents as a
chronic eczematous change of the nipple often with an
underlying palpable lump. Classically the underlying car-
cinoma is invasive in nature although in 40–45% of cases
the underlying pathology is DCIS. A prerequisite to the
development of this condition is the presence of the nip-
ple or at least underlying mammary tissue both of which
were absent in this case. We present a case of a 39 year old
lady who re-presented with Pagets disease following mas-
tectomy and latissimus dorsi reconstruction, in the
absence of a nipple or underlying breast tissue.
Case presentation
A 39 year old lady was referred to our breast unit with a
one week history of a lump in the lateral aspect of the right
breast. On examination, a generalized hardness was felt in
the right breast together with central retraction of the nip-
ple.
Mammography revealed malignant microcalcification
affecting the whole breast with core biopsy proving high
grade ductal carcinoma in situ (DCIS).
Following discussion at the multi disciplinary meeting,
she underwent a mastectomy and axillary sampling
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together with an immediate latissimus dorsi (LD) recon-
struction flap. Post-operative recovery was unremarkable
and the cosmetic result was good.
Histology of the breast revealed 120 mm of high grade
DCIS of mixed comedo and solid type. Two separate foci
of invasive ductal carcinoma (Grade 1 and Grade 2) were
identified. The margins were clear of tumour by 1.3 mm
(in-situ disease) and 5.8 mm (invasive component). No
evidence of Paget's disease was documented at this time.
The axillary sample was negative for tumour.
As the tumour demonstrated strong Estrogen/Progester-
one positivity, Mrs K.S was started on postoperative
Tamoxifen treatment but this was discontinued within 6
months due to adverse side effects. On her second post-
operative visit, a small erythematous skin lesion was
noted on the superio-medial aspect of the flap adjacent to
the scar (Fig 1).
A punch biopsy was obtained which revealed foci of atyp-
ical cells within the epidermis with Pagetoid spread.
Immunostaining showed positivity for CAM 5.2, CEA and
EMA, consistent with. Paget's disease.
A wide local excision of the lesion was performed and the
specimen was sent for a histological second opinion. This
showed acanthosis, hyperkeratosis with focal parakerato-
sis and extensive replacement of the epidermis by pleo-
morphic epithelial cells with marked pagetoid pattern
(Fig 2). Tumour cells extended into adjacent hair follicles
and immunohistochemistry confirmed features of Paget's
disease.
The differential diagnosis was between that of Paget's dis-
ease of the breast (although there was no underlying
breast tissue or nipple and it was not seen in the original
mastectomy specimen) and extra-mammary Paget's dis-
ease of the skin.
Because of the past history of breast carcinoma, a diagno-
sis of Paget's disease of the breast was made.
Conclusion
Paget's disease of the breast was first described by Sir
James Paget in 1874 [1] who described "an eczematous
change in the skin of the nipple preceeding an underlying
mammary cancer". It occurs in 1 – 4% of all female breast
carcinoma cases and is invariably associated with underly-
ing malignancy either overt or occult. The majority of
these cases are invasive disease although 40–45% are
associated with DCIS [2].
Opinion is divided regarding the pathogenesis of this con-
dition.
It is thought that malignant epithelial cells from intraduc-
tal carcinoma, extend into the overlying epidermis
through mammary duct epithelium and proliferate in the
epidermis causing thickening of the nipple and areolar
skin. This is supported by the observation that Paget cells
often share cell surface markers with the underlying breast
carcinoma (e.g CAM 5.2, CEA, c-erb 2 and EMA) [3,4].
Normal epidermal keratinocytes produce and release the
mobility factor heregulin-alpha which is chemotactic for
heregulin receptors (Her-2) and coreceptors Her 3 and
Her 4 which are produced by Pagets cells. This is thought
to result in migration of these cells to the nipple epidermis
[5].
Histological section of skin showing malignant glandular epi- thelial cells within the epidermis (Paget's disease) H&E ×200 Figure 2
Histological section of skin showing malignant glandular epi-
thelial cells within the epidermis (Paget's disease) H&E ×200.
Recurrent nodule in the latissimus dorsi reconstruction scar Figure 1
Recurrent nodule in the latissimus dorsi reconstruction scar.Publish with BioMed Central    and   every 
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Others believe that Paget's cells are derived from clear nip-
ple epithelium (Toker) cells [6] and that underlying intra-
ductal carcinoma is simply coexisting with this disease
[7].
Extramammary Paget's disease was first described by Rad-
cliffe Crocker in 1889. It is histologically identical but
anatomically different to mammary Paget's disease affect-
ing sites rich in apocrine glands such as the genetalia, axil-
lae, perineum, and external auditory canal [8,9]. Unlike
mammary Paget's disease, the majority (75%) of cases
arise de-novo as a primary cutaneous adenocarcinoma
with the epidermis being infiltrated by neoplastic cells
showing glandular differentiation. In the remaining 25%
there is an associated underlying in-situ or invasive carci-
noma, most commonly a primary adnexal apocrine carci-
noma which produces the skin lesion as a secondary event
[10].
In our case, following mastectomy and latissimus dorsi
reconstruction, a focus of Paget's disease was found in the
scar bridging the breast and transplanted skin. Neither of
these areas are apocrine rich and therefore would be
unlikely candidates for extramammary Paget's disease. In
the absence of a a nipple, underlying ductal epithelium or
breast tissue in general it is also very hard to explain as
part of mammary Paget's disease.
In this case, neoplastic cells from an axillary apocrine car-
cinoma may have migrated up the hair follicle and along
the surgical scar but the exact pathogenesis still remains
unclear.
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